Wei Cao

Also affiliated with Northwest University, Second Xiangya Hospital of Central South University

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Comp34 displays potent preclinical antitumor efficacy in triple-negative breast cancer via inhibition of NUDT3-AS4, a novel oncogenic long noncoding RNA”.

Comp34 displays potent preclinical antitumor efficacy in triple-negative breast cancer via inhibition of NUDT3-AS4, a novel oncogenic long noncoding RNA

Cell Death and Disease(2020)10.1038/s41419-020-03235-w

N/A

0DataRank · unranked

20 citations

Piwen Wang, Pranabananda Dutta, Seyung Chung, Qun Li, Kun Wang +14 more

Inhibition of triple‑negative breast cancer proliferation and motility by reactivating p53 and inhibiting overactivated Akt

Oncology Reports(2021)10.3892/or.2021.8252

N/A

0DataRank · unranked

30 citations

Renhui Shen, Seth Richard, Yu Liu, Mohammad Jalalirad, Margot P. Cleary +4 more